Enzymatic tests in the prognosis and course controls in bronchial carcinoma patients.
In 117 bronchial carcinoma patients hospitalized to receive radiation therapy, the serum levels of aldolase, LDH, alkaline phosphatase, GOT and GPT were checked prior to, during, and following radiation therapy at intervals of 4--6 weeks. Among the enzymes tested, aldolase proved to provide the best screening test for judging prognosis, course of disease and probable occurrence of recurrence or metastases.
D000230:Adenocarcinoma / Q000201:enzymology; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002277:Carcinoma / Q000201:enzymology; D002283:Carcinoma, Bronchogenic / Q000201:enzymology*; D002294:Carcinoma, Squamous Cell / Q000201:enzymology; D004796:Clinical Enzyme Tests; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008175:Lung Neoplasms / Q000201:enzymology*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000201:enzymology; D011379:Prognosis
D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005634:Fructose-Bisphosphate Aldolase